Major depressive disorder (MDD) is a severe form of depression characterized by a persistent low mood, hopelessness, ...
MedPage Today on MSN
Psilocybin Failed to Live Up to Hype for Treatment-Resistant Depression
Researchers questioned psychedelic's true efficacy in unblinded trials ...
You’ve probably heard someone say exercise is “good for your head.” And you’ve probably nodded, filed it under vaguely true advice, and moved on. But here’s the thing: exercise doesn’t just help your ...
Understanding what depression is – and what it is not – is often the first step toward relief.
Methylone is a drug that is thought to enhance neuroplasticity. In a recent clinical trial, this drug led to clinically meaningful improvement in symptoms of PTSD.
Explore NMDA receptor modulation and its critical role in neuronal development and cognitive functions like learning and memory.
Recent research has opened the debate on whether chemical imbalances cause depression, anxiety, and other conditions ...
NYSE-listed Alto Neuroscience has raised $120 million in a private placement that will be used to advance its recently acquired candidate for treatment-resistant depression (TRD) into a pivotal trials ...
Neurocrine Biosciences has rebounded 60% since April 2025, driven by robust Ingrezza sales and Crenessity's uncontested launch. Read why NBIX stock is a hold.
Major depressive disorder, often called MDD, is one of the most serious and common mental health conditions in the world. People with this condition often experience a long-lasting low mood, feelings ...
Millions of people live with nerve pain that never seems to go away. This kind of pain can feel like burning, tingling, ...
Worcester Telegram on MSNOpinion
Opinion/Guest column: Weighing risks of SSRIs during pregnancy
The individualized decision for a woman to take an SSRI during pregnancy is not a risk versus benefit analysis but a risk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results